O
Power Law company profile
OSE Immunotherapeutics
Biotech & Life Sciences · Nantes, France · Founded 2012 · IPO 2015 Colt
Valuation
$121M
Market cap · Apr/2026
Revenue
$92M
Latest reported FY
EBITDA
$54M
Latest reported FY
Featured in
$1B+ revenueColt · Power Law growth-stage
Global footprint
Where OSE Immunotherapeutics has talent and traffic
Web traffic by country
3.4K
monthly visits
across markets
across markets
🇫🇷 France135.3%
🇺🇸 United States58.8%
🏳️ Korea35.3%
🏳️ Republic of17.6%
🇮🇳 India8.8%
Market sentiment
What the market is saying about OSE Immunotherapeutics
An AI-synthesized read of the highest-engagement posts about OSE Immunotherapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OSE Immunotherapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.